10-Propargyl-10-Deazaaminopterin in Treating Patients With Recurrent or Refractory Non-Hodgkin’s Lymphoma or Hodgkin’s Lymphoma
Condition(s):LymphomaLast Updated:August 25, 2021Completed
Hide Studies Not Open or Pending
Condition(s):LymphomaLast Updated:August 25, 2021Completed
Condition(s):Unspecified Adult Solid Tumor, Protocol SpecificLast Updated:June 26, 2013Completed
Condition(s):Lung CancerLast Updated:June 19, 2013Completed
Condition(s):Peripheral T-cell LymphomaLast Updated:December 19, 2019Completed
Condition(s):Breast Cancer; Breast Tumors; Neoplasms, Breast; Cancer of the Breast; Human Mammary CarcinomaLast Updated:January 7, 2020Completed
Condition(s):Anaplastic Large Cell Lymphoma; Nodal Peripheral T-Cell Lymphoma With TFH Phenotype; Recurrent Anaplastic Large Cell Lymphoma; Recurrent Angioimmunoblastic T-Cell Lymphoma; Recurrent Enteropathy-Associated T-Cell Lymphoma; Recurrent Follicular Lymphoma; Recurrent Hepatosplenic T-Cell Lymphoma; Recurrent Mature T- Cell and NK-Cell Non-Hodgkin Lymphoma; Recurrent Monomorphic Epitheliotropic Intestinal T-cell Lymphoma; Recurrent Mycosis Fungoides; Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified; Refractory Anaplastic Large Cell Lymphoma; Refractory Angioimmunoblastic T-Cell Lymphoma; Refractory Enteropathy-Associated T-Cell Lymphoma; Refractory Follicular Lymphoma; Refractory Hepatosplenic T-Cell Lymphoma; Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma; Refractory Mycosis Fungoides; Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified; Subcutaneous Panniculitis-Like T-Cell LymphomaLast Updated:March 6, 2024Active, not recruiting
Condition(s):Adenocarcinoma of the Gastroesophageal Junction; Esophageal Undifferentiated Carcinoma; Gastric Adenocarcinoma; Gastric Squamous Cell Carcinoma; Recurrent Esophageal Adenocarcinoma; Recurrent Esophageal Squamous Cell Carcinoma; Recurrent Gastric Carcinoma; Stage IIIB Esophageal Adenocarcinoma; Stage IIIB Esophageal Squamous Cell Carcinoma; Stage IIIB Gastric Cancer; Stage IIIC Esophageal Adenocarcinoma; Stage IIIC Esophageal Squamous Cell Carcinoma; Stage IIIC Gastric Cancer; Stage IV Esophageal Adenocarcinoma; Stage IV Esophageal Squamous Cell Carcinoma; Stage IV Gastric Cancer; Undifferentiated Gastric CarcinomaLast Updated:December 13, 2017Completed
Condition(s):Peripheral T-cell LymphomaLast Updated:November 19, 2021Terminated
Condition(s):Cutaneous T-cell LymphomaLast Updated:January 3, 2020Completed
Condition(s):Lymphoma, B-CellLast Updated:November 5, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.